A Study of TAVO412 in Patients with Cancer
Clinical trial NCT05548634 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05548634
- Sponsor
- Tavotek Biotherapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-08
- Primary completion
- 2025-12-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.